Rheumatologists’ Disease-modifying Antirheumatic Drug Preferences for Rheumatoid Arthritis: Results from a Survey in Nigeria
MTX remains the DMARD of first choice for RA among Nigerian rheumatologists. Conventional synthetic DMARDs are the commonly available, widely used, and still effective armamentarium for RA in resource-poor settings like Nigeria. bDMARDs prescription rate for RA remains low in Nigeria.
Authors
- Birinus Ezeala‐Adikaibe (ORCID: https://orcid.org/0000-0003-1185-6528)
- Ugochi Chika Onu (ORCID: https://orcid.org/0000-0001-8165-0918)
- Okwara Celestine Chibuzo (ORCID: https://orcid.org/0000-0002-7727-5657)
- Nkeiruka Chigekwu Mbadiwe
- Michael Chinweuba Abonyi (ORCID: https://orcid.org/0000-0002-9825-8469)
- Ijeoma Ndionuka
- Ijeoma Onwuchekwa
- Fintan Ekochin
- Winifred Njideka Adiri
- Nkiruka Pauline Onodugo
Institutions
- Enugu State University of Science and Technology (NG)
- University of Nigeria Teaching Hospital (NG)
Publication Details
- Journal
- Annals of African Medicine
- Published
- 2025-08-04
- DOI
- https://doi.org/10.4103/aam.aam_98_25
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00